Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections.
17 Dec, 2021 | 09:54h | UTCCommentaries:
Novavax COVID vaccine shows 90.4% efficacy against infection – CIDRAP
Novavax COVID-19 vaccine found to be safe and effective – University of Maryland School of Medicine
Related: [Preprint] In RCT with 29,949 participants, the Novavax vaccine demonstrated high overall efficacy (>90%) for the prevention of Covid-19, and all moderate-to-severe cases occurred in placebo recipients. (several articles on the subject)